EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

The Effect of Adding Selenium to the Treatment Regimen on Outcomes of Patients with COVID-19: A Randomized Clinical Trial

Tahoura Afshari Saleh, Seyed Taha Hoseini, Davood Soroosh, Afsaneh Kaffash, Lahya Afshari Saleh

Journal of Kerman University of Medical Sciences · 06.01.2026 · 33 · 3978

DOI: 10.34172/jkmu.3978 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Kerman University of Medical Sciences, online erschienen am 06.01.2026. Verfasst von Tahoura Afshari Saleh und 4 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Some studies indicate that selenium is essential in the host’s response to viral infections. This study aimed to investigate the effect of selenium administration on clinical outcomes in hospitalized patients with COVID-19.

Methods

This clinical trial was conducted in Sabzevar in 2020–2021 (registration code: IRCT20160706028815N5) on hospitalized patients with COVID-19. Demographic data, clinical symptoms, and CT scan findings were recorded. The participants were randomly divided into two groups. The control group received standard care based on the latest national treatment protocols for COVID-19. The intervention group received selenium in addition to routine treatment. Clinical outcomes were compared between the two groups using SPSS statistics software. A significance level of 0.05 was considered.

Results

Fifty-four patients were randomly assigned to the intervention (n=29) and control (n=25) groups. Twenty-nine men (53.7%) and 25 women (46.3%) were included in the study. The mean and SD of age and body mass index of participants were 58.3±16.8 and 25.8±3.3, respectively. The groups were similar in terms of gender, addiction, smoking, commodities, symptoms, amount of pulmonary parenchyma involvement in the lung CT scan, age, and body mass index. The duration of admission was significantly shorter in the intervention group (P=0.03). There was no significant difference in terms of ICU admission, mechanical ventilation, and 30- and 90-day mortality rates.

Conclusion

The present study showed that the administration of selenium can reduce the duration of the disease. Other clinical outcomes did not show significant differences between the two groups.

Zitieren

APA

Saleh, T. A., Hoseini, S. T., Soroosh, D., Kaffash, A., & Saleh, L. A. (2026). The Effect of Adding Selenium to the Treatment Regimen on Outcomes of Patients with COVID-19: A Randomized Clinical Trial. Journal of Kerman University of Medical Sciences, 33, 3978. https://doi.org/10.34172/jkmu.3978

Vancouver

Saleh TA, Hoseini ST, Soroosh D, Kaffash A, Saleh LA. The Effect of Adding Selenium to the Treatment Regimen on Outcomes of Patients with COVID-19: A Randomized Clinical Trial. Journal of Kerman University of Medical Sciences. 2026;33:3978. doi:10.34172/jkmu.3978

BibTeX
@article{Saleh2026,
  author = {Saleh, Tahoura Afshari and Hoseini, Seyed Taha and Soroosh, Davood and Kaffash, Afsaneh and Saleh, Lahya Afshari},
  title = {The Effect of Adding Selenium to the Treatment Regimen on Outcomes of Patients with COVID-19: A Randomized Clinical Trial},
  journal = {Journal of Kerman University of Medical Sciences},
  year = {2026},
  volume = {33},
  pages = {3978},
  doi = {10.34172/jkmu.3978}
}
Kostenlos starten →